AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32595060
Drug: Development group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Development group (Endovascular treatment)
Trial: 32595060
Drug: Validation sample
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Validation sample (Endovascular treatment)
Trial: 36274468
Drug: Abdominal massage
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal massage for 3 days, twice a day, for 15 minutes
Trial: 32742507
Drug: Remote ischemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote ischemic conditioning (twice daily with a maximum of 180 mmHg for 5 days)
Trial: 32437332
Drug: ID +
RxNorm normalized name: Olly Prenatal Folic Acid + DHA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID + IL-12 (1.6 mg ID + 0.4 mg pIL-12)
Trial: 32437332
Drug: IM +
RxNorm normalized name: Jarrow Formulas DIM + CDG Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM + IL-12 (8 mg IM + 1 mg pIL-12)
Trial: 32437332
Drug: ID no
RxNorm normalized name: red, acid no.17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID no IL-12 (1.6 mg ID)
Trial: 33439265
Drug: Bimagrumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimagrumab (10 mg/kg up to 1200 mg in 5% dextrose solution) every 4 weeks for 48 weeks
Trial: 33439265
Drug: Placebo (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5% dextrose solution) every 4 weeks for 48 weeks
Trial: 36206262
Drug: Prophylactic acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic acetaminophen and ibuprofen every 6 hours for 72 hours
Trial: 36206262
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (acetaminophen every 6 hours for a temperature ≥ 38.5°C)
Trial: 34554693
Drug: Single-shot thoracic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-shot thoracic paravertebral block combined with intravenous analgesia (Group P)
Trial: 34195628
Drug: 30 tablets
RxNorm normalized name: nitrogen 30 %
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Trial: 34195628
Drug: 60 tablets
RxNorm normalized name: Polysorbate 60
DrugBank: Polysorbate 60 (DB14153)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Trial: 32580739
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive therapy during pregnancy
Trial: 34028494
Drug: Online communication
RxNorm normalized name: cocklebur pollen extract
DrugBank: Xanthium strumarium pollen (DB10356)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online communication training for clinicians (3 sequential online educational modules and weekly text messages)
Trial: 34404983
Drug: Midazolam monotherapy
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam monotherapy
Trial: 35801782
Drug: Control care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control care (CC) group
Trial: 34255136
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (3 g daily)
Trial: 35841235
Drug: mRNA vaccine
RxNorm normalized name: RSV mRNA vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mRNA vaccine (M group; n = 43)
Trial: 35841235
Drug: Viral vector
RxNorm normalized name: Mx-dnG1 retroviral vector
DrugBank: Rexin G (DB16450)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral vector vaccine (V group; n = 42)
Trial: 35841235
Drug: mRNA vaccine
RxNorm normalized name: RSV mRNA vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mRNA vaccine (M group)
Trial: 35841235
Drug: Viral vector
RxNorm normalized name: Mx-dnG1 retroviral vector
DrugBank: Rexin G (DB16450)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral vector vaccine (V group)
Trial: 34323924
Drug: Metformin (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2000 mg/d) during chemoradiotherapy and afterward for up to 12 months
Trial: 34323924
Drug: Control (platinum-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (platinum-based chemotherapy with concurrent chest radiotherapy)
Trial: 38309227
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg 5-HTP daily
Trial: 32062860
Drug: Post-operative medication
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative medication checklist
Trial: 32062860
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (post-operative pain medication plus VAS form)
Trial: 35063244
Drug: Cranberry group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry group (500 mg dry cranberry extract, 2 times daily for 2 months)
Trial: 35063244
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (500 mg corn starch, 2 times daily for 2 months)
Trial: 34032479
Drug: Single-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose IV administration of MMF (2.5 mg/kg)
Trial: 34032479
Drug: Single-dose PO
RxNorm normalized name: Zithromax 1g Single-Dose Powder for Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose PO administration of MMF (5 mg/kg)
Trial: 34032479
Drug: Long-term PO
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term PO administration of MMF (5 mg/kg, PO, q 24 h for 30 days and then 5 mg/kg, PO, q 48 h for an additional 30 days)
Trial: 34328481
Drug: SLA surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLA surface implants (Group 1)
Trial: 34328481
Drug: Fluorine-modified surface
RxNorm normalized name: fluorine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorine-modified surface implants (Group 2)
Trial: 34328481
Drug: Anodized surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anodized surface implants (Group 3)
Trial: 33132344
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g RMD three times daily
Trial: 36214230
Drug: Ultrasound-guided trigger
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided trigger point injection (TPI)
Trial: 32666079
Drug: Other anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other anti-inflammatory treatments (e.g., methotrexate in Cardiovascular Inflammation Reduction Trial)
Trial: 34224601
Drug: Acoustic subcision
RxNorm normalized name: aconite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acoustic subcision treatment
Trial: 35537314
Drug: Satralizumab (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satralizumab (120 mg subcutaneous)
Trial: 35537314
Drug: Steroid tapering
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Steroid tapering
Trial: 34116009
Drug: Evaluation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evaluation of IOL rotational stability using nontoric implants in 25 patients with 2 consecutive follow-up visits.
Trial: 32654212
Drug: Inotersen 300
RxNorm normalized name: INOTERSEN
DrugBank: Inotersen (DB14713)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inotersen 300 mg weekly for 65 weeks
Trial: 35243125
Drug: WATSU (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WATSU (a passive hands-on treatment in warm water)
Trial: 616782981
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia combined with nerve block
Trial: 32133503
Drug: Milk (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk (600 mL)
Trial: 32133503
Drug: Cheese (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cheese (100 g)
Trial: 32133503
Drug: Soy-based drink
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy-based drink (600 mL)
Trial: 36121672
Drug: Rituximab (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (500 mg intravenous infusion)
Trial: 34314018
Drug: belantamab mafodotin
RxNorm normalized name: belantamab mafodotin
DrugBank: Belantamab mafodotin (DB15719)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: belantamab mafodotin (belamaf) 2.5 mg/kg
Trial: 35371086
Drug: Prednisone +
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone + Methotrexate (MTX) 10 mg orally every week
Trial: 35469143
Drug: Barley-based remedy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barley-based remedy plus conventional medicine
Trial: 36379530
Drug: Corticosteroids (CS)
RxNorm normalized name: MyoGesic-CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (CS) injections
Trial: 35288599
Drug: Dexamethasone 0.25
RxNorm normalized name: dexamethasone 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.25 mg/kg every 6 hours, 6-12 hours prior to extubation (four doses)
Trial: 34074214
Drug: Fecal microbiota
RxNorm normalized name: Fecal Microbiota
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fecal microbiota transplantation (FMT) with 25 daily multi-donor FMT capsules for 12 days
Trial: 35869616
Drug: 3-day aspirin
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-day aspirin
Trial: 35869616
Drug: 0-day aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0-day aspirin + 3-day clopidogrel
Trial: 35869616
Drug: 3-day aspirin
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-day aspirin + 7-day clopidogrel
Trial: 35869616
Drug: 0-day aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0-day aspirin + 7-day clopidogrel
Trial: 32295718
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose influenza vaccine (HD) - Sanofi Pasteur Fluzone High Dose [60 mcg × 3 strains]
Trial: 32295718
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose influenza vaccine (SD) - Sanofi Pasteur Fluzone® [15 mcg × 3 strains]
Trial: 34145518
Drug: Relational Agent
RxNorm normalized name: Latanoprost related compound e
DrugBank: Latanoprost acid (DB19360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relational Agent + TAU
Trial: 32030573
Drug: Nicosulfuron at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicosulfuron at 6 g a.e. ha‐1
Trial: 32030573
Drug: Nicosulfuron at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicosulfuron at 12 g a.e. ha‐1
Trial: 32030573
Drug: Nicosulfuron at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicosulfuron at 24 g a.e. ha‐1
Trial: 32030573
Drug: Nicosulfuron at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicosulfuron at 48 g a.e. ha‐1
Trial: 32030573
Drug: Nicosulfuron at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicosulfuron at 60 g a.e. ha‐1
Trial: 32030573
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 g a.e. ha‐1)
Trial: 34787246
Drug: Control (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (without pre-treatment)
Trial: 35933942
Drug: Extended-release injectable
RxNorm normalized name: Exenatide for Extended-Release Injectable Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release injectable naltrexone (XR-NTX) before release
Trial: 35933942
Drug: Extended-release injectable
RxNorm normalized name: Exenatide for Extended-Release Injectable Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release injectable naltrexone (XR-NTX) referral after release
Trial: 34783956
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care together with use of the PROMPT‐QoL
Trial: 34783956
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care only
Trial: 33277746
Drug: EVL/MPA/steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVL/MPA/steroids
Trial: 34627499
Drug: Antimicrobial stewardship
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial stewardship intervention (education, engaging opinion leaders, prospective audit and feedback of antibiotic use)
Trial: 34627499
Drug: Control period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control period (broad-spectrum antibiotics)
Trial: 34627499
Drug: Intervention period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention period (antibiotic stewardship)
Trial: 35555211
Drug: Mid-Luteal (ML)
RxNorm normalized name: Nuphar lutea leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mid-Luteal (ML) phase
Trial: 36481522
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate and nicardipine (combination therapy)
Trial: 34034418
Drug: Mifepristone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 10 mg/day
Trial: 36127081
Drug: Ecological Momentary
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ecological Momentary Intervention called SmartSafe in addition to treatment as usual (TAU)
Trial: 36127081
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) with monitoring using Ecological Momentary Assessment (EMA)
Trial: 34607597
Drug: Free gingival
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free gingival graft (FGG) before implant placement
Trial: 34607597
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (without FGG before implant placement)
Trial: 33197414
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg IV ibuprofen
Trial: 35777250
Drug: Heart Rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart Rate Variability (HRV) biofeedback treatment including at-home breathing practice
Trial: 34165508
Drug: 5 years
RxNorm normalized name: Dymadon 5 Years Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 years of zoledronate treatment (4 mg intravenously every 3 months for 2 years, followed by 4 mg intravenously every 6 months for 3 years)
Trial: 34165508
Drug: 2 years
RxNorm normalized name: Childrens Panadol 5 - 12 Years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 years of zoledronate treatment (4 mg intravenously every 3 months for 2 years)
Trial: 34165508
Drug: 5 years
RxNorm normalized name: Dymadon 5 Years Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 years of zoledronate treatment
Trial: 34165508
Drug: 2 years
RxNorm normalized name: Childrens Panadol 5 - 12 Years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 years of zoledronate treatment
Trial: 33272042
Drug: Kaempferia parviflora
RxNorm normalized name: Kaempferia galanga root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kaempferia parviflora extract (360 mg/day)
Trial: 33264337
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) 400 mg twice for 1 day or HCQ 200 mg twice daily for 6 days
Trial: 36229051
Drug: Guideline-based heart
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-based heart failure treatment alone (Control)
Trial: 32152503
Drug: Pembrolizumab 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 200 mg I.V. every 3 weeks
Trial: 33626326
Drug: Topical Oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Oxygen Jet Therapy (TOJT)
Trial: 36124112
Drug: Topical sesame
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sesame oil
Trial: 33662054
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of manual and machine-aided cleaning
Trial: 35102749
Drug: Belt electrode
RxNorm normalized name: ELECTRODE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belt electrode skeletal muscle electrical stimulation (B-SES) combined with conventional physical therapy for 20 minutes each
Trial: 35102749
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy for 20 minutes
Trial: 33888413
Drug: Insulin‐alone artificial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin‐alone artificial pancreas
Trial: 33888413
Drug: Final dual-hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Final dual-hormone system (insulin and pramlintide)
Trial: 33888413
Drug: Insulin‐alone arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin‐alone arm
Trial: 35837984
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump (with or without CGM)
Trial: 32135648
Drug: Chrono-chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chrono-chemotherapy combined with intensity modulated radiotherapy (IMRT)
Trial: 32135648
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy combined with intensity modulated radiotherapy (IMRT)
Trial: 32135648
Drug: Chrono-chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chrono-chemotherapy combined with IMRT
Trial: 32135648
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy combined with IMRT
Trial: 33815657
Drug: L-Arginine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Arginine (5 grams per day)
Trial: 34082142
Drug: Fresh pomegranate
RxNorm normalized name: Pomegranate
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh pomegranate juice (250 mL twice daily for 2 weeks)
Trial: 34831554
Drug: AET +
RxNorm normalized name: beta-Aet
DrugBank: HE-2200 (DB06257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AET + ISP (40 g/day, 5 days a week for 8 weeks)
Trial: 32056945
Drug: Brief cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief cognitive behavioral therapy (BCBT)
Trial: 32532339
Drug: Adolescents with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adolescents with good oral hygiene
Trial: 32013277
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg bolus followed by 0.12 mg/kg/h continuous infusion)
Trial: 35266869
Drug: Telephone group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone group (questionnaires administered during a telephone interview)
Trial: 32078929
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for dissociative seizures
Trial: 33685421
Drug: S-1 monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 monotherapy (80 mg/m2 orally administrated twice daily, at day 1–14, 16 cycles)
Trial: 33685421
Drug: Cisplatin with
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin with vinorelbine combination therapy (cisplatin 80 mg/m2 at day 1, vinorelbine 25 mg/m2 at day 1, 8, 4 cycles)
Trial: 35382963
Drug: Lidocaine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (2 mg/kg/h)
Trial: 35382963
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg/h)
Trial: 35382963
Drug: Dexmedetomidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.5 mcg/kg/h)
Trial: 34985236
Drug: End-range Maitland
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End-range Maitland mobilization (MG)
Trial: 32819981
Drug: Weekly mood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly mood message (control group)
Trial: 34490850
Drug: ISC 17536
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISC 17536 (28-day administration)
Trial: 34490850
Drug: Placebo (28-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (28-day administration)
Trial: 39173098
Drug: pembrolizumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pembrolizumab plus chemotherapy